UBS revises its EBITDA guidance

(CercleFinance.com) - UBS confirms its neutral recommendation on the stock, with a target price of E130, representing a potential upside of 10%.


'Lower traffic estimates and higher operating expenses lead to EBITDA revisions for 2024/2025/2026 of -1.5%/-1.3%/-1.3%', says UBS.

The target of at least 4% EBITDA growth in 2024 is confirmed, as are our other assumptions, forecasts and targets for 2024 and 2025", said Augustin de Romanet, Chairman and CEO.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.